MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91

File: 970101_sep96_decls1_0007.txt
Page: 0007
Total Pages: 194

Subject: MEDICAL BIO WARFARE DEFENSE PLAN  8 APR 91                      

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003202

Folder Title: MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN                                                   

Document Number:          2

Folder Seq  #:         25




                                         In r fN r-I r2:
                                                      UNCLASSIFIED




           DASG-HCD-D
           SUBJECT: Medical Biological Warfare (BW) Defense Plan (U)


                b. (U) Establish the Joint Medical Biological Warfare Defense
           Committee (JMBWDC) to monitor requirements for and stocks of
           vaccines, antitoxins, and immune globulins. This committee will
           make recommendations on vaccination of U.S. Forces against BW
           agents.

                C. (U) Immunize the services' designated early deploying
           forces during peacetime against specific Bw agents to maximize
           readiness and deployment posture. Amend immunization regulation.
           Funding is a service responsibility. -

                d. (U) Establish a government owned, contractor operated
           facility to produce vaccines, toxoids, and antitoxin to support DOD
           missions.

                e. (U) Decentralize storage of vaccines, antitoxin, and immune
           globulin for security purposes.

                f. (U) Store vaccines in bulk to extend shelf-life to greater
           than ten years to minimize fiscal impact while maximizing BW
           defensive capabilities.

                g. (U) Maintain industrial base for vaccine and antitoxin
           production by establishing annual requirements in 5b. Also
           maintain CONUS industrial base antibiotic production to ensure
           treatment capability against anthrax.

                h. (U) Finalize the TRADOC boarding process for the Theater
           Army Medical Laboratory which is designed to identify BW agents
           used against U.S. Forces.

                i. @ Establish a MOU between Department of Defense and
                                                  to exchange suspected BW
           samples for double verification of BW attack on either country's
e basis
           for retaliation against opposing force(s) using BW agents.

                j. (U) Make vaccines and antitoxins available to select allies
           through Foreign Military Sales to avoid future geopolitical issues.

           6. (U) Point of contact for this action.is MAJ Robert Eng,
           DASG-HCD-D, 756-8163.

           FOR THE SURGEON GENERAL:




           Encl                             BRUCE T.        NAC
                                            Brigadier General, MS
                                            Director, Health Care Operations
                                                @IUWJ.HY
                             UNCLASSIFIED      2COlonal, MS          cam
                                                @ecuty Director, R@th

Document 194 f:/Week-36/BX003202/MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN/medical bio warfare defense plan 8 apr 91:1224960931152
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE - BW- DEFENSE PLAN
Folder Seq # = 25
Subject = MEDICAL BIO WARFARE DEFENSE PLAN 8 APR 91
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996